差價合約是複雜的工具，並且由於槓桿作用而具有快速虧損的高風險。 84% 的散戶投資者賬戶在與該提供商交易差價合約時虧損。您應該考慮自己是否了解差價合約的運作方式，以及您是否有能力承擔損失資金的高風險。
Country • United States
    Entity • country not supported, please select another country
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    交易 Bolt Biotherapeutics, Inc. - BOLT CFD

    1.3577
    3.03%
    • 概括
    • 曆史數據
    • 活動
    • 收入報表
    • 資産負債表
    • 現金流
    • 所有權
    交易條件
    價差 0.0346
    多頭倉位隔夜費用

    Long position overnight fee

    Margin. Your investment $1,000.00
    隔夜費用 -0.024874 %
    Charges from borrowed part ($-0.99)
    Trade size with leverage ~ $5,000.00
    來自槓桿的資金 ~ $4,000.00
    前往平台
    		-0.024874%
    空頭倉位隔夜費用

    Short position overnight fee

    Margin. Your investment $1,000.00
    隔夜費用 0.002651 %
    Charges from borrowed part ($0.11)
    Trade size with leverage ~ $5,000.00
    來自槓桿的資金 ~ $4,000.00
    前往平台
    		0.002651%
    隔夜費時間 21:00 (UTC)
    最小成交量 1
    貨幣 USD
    保證金 20%
    股票交易 United States of America
    交易委員會 0%

    *Information provided by Capital.com

    關鍵數據
    前收盤價* 1.3178
    開盤價* 1.2978
    1 年變化* -52.64%
    日範圍* 1.2978 - 1.3677
    52 周範圍 1.18-3.14
    平均交易量（10 天） 429.33K
    平均交易量（3 個月） 5.97M
    市值 50.47M
    市盈率 -100.00K
    流通股 37.81M
    收入 5.73M
    EPS -2.36
    股息（收益率 %） N/A
    貝塔 -100.00K
    下一個財報發布日期 May 10, 2023

    所有數據都是由Refinitiv提供的， 除了標有星號的數據， 這是*由 Capital.com 提供的數據

    • 上週
    • 上個月
    • 去年
    • 過去兩年
    • 最大
    • 每日
    • 每週
    • 每月
    日期 關閉 更改 變化 (%) 打開 高 低
    Mar 31, 2023 1.3577 0.0599 4.62% 1.2978 1.3677 1.2978
    Mar 30, 2023 1.3178 -0.0199 -1.49% 1.3377 1.3377 1.1979
    Mar 29, 2023 1.2878 -0.0499 -3.73% 1.3377 1.3776 1.2778
    Mar 28, 2023 1.2978 -0.0199 -1.51% 1.3177 1.3377 1.2578
    Mar 27, 2023 1.3377 0.0399 3.07% 1.2978 1.3377 1.2978
    Mar 24, 2023 1.3178 0.0200 1.54% 1.2978 1.3377 1.2978
    Mar 23, 2023 1.3078 -0.0598 -4.37% 1.3676 1.4076 1.3078
    Mar 22, 2023 1.4076 -0.0599 -4.08% 1.4675 1.4675 1.3776
    Mar 21, 2023 1.4475 0.0499 3.57% 1.3976 1.4975 1.3776
    Mar 20, 2023 1.4176 0.0200 1.43% 1.3976 1.4376 1.3676
    Mar 17, 2023 1.4176 -0.0499 -3.40% 1.4675 1.4875 1.3976
    Mar 16, 2023 1.4975 0.0699 4.90% 1.4276 1.5174 1.4176
    Mar 15, 2023 1.4675 0.0699 5.00% 1.3976 1.4975 1.3976
    Mar 14, 2023 1.5075 0.1099 7.86% 1.3976 1.5075 1.3976
    Mar 13, 2023 1.3976 0.1098 8.53% 1.2878 1.4076 1.2678
    Mar 10, 2023 1.2678 -0.1198 -8.63% 1.3876 1.3877 1.2678
    Mar 9, 2023 1.3876 -0.1298 -8.55% 1.5174 1.5674 1.3677
    Mar 8, 2023 1.5773 -0.0200 -1.25% 1.5973 1.5973 1.5274
    Mar 7, 2023 1.6073 0.0599 3.87% 1.5474 1.6273 1.5474
    Mar 6, 2023 1.5674 -0.0898 -5.42% 1.6572 1.6672 1.5174

    Bolt Biotherapeutics, Inc. Events

    时间（协调世界时） (UTC) 国家 事件
    No events scheduled
    查看所有活动
    • 年度
    • 每季度
    2021 2020 2019 2018
    總收入 1.26 0.231 0.215 0
    收入 1.26 0.231 0.215 0
    總營業費用 94.048 49.413 31.184 11.629
    銷售/一般/行政費用，總計 18.393 9.056 5.182 2.209
    研究與開發 75.655 40.357 26.002 9.42
    營業收入 -92.788 -49.182 -30.969 -11.629
    利息收入（費用），非經營淨值 0.281 0.199 0.524 0.193
    其他，淨值 -6.084 -11.745 -0.042 -0.153
    稅前淨收入 -98.591 -60.728 -30.487 -11.589
    稅後淨收入 -98.591 -60.728 -30.487 -11.589
    未計算非常項目前的淨收益 -98.591 -60.728 -30.487 -11.589
    淨收入 -98.591 -60.728 -30.487 -11.589
    普通股股東可獲收益 (不含非經常性項目) -98.591 -60.728 -30.487 -11.589
    普通股股東可獲收益 (含非經常性項目) -98.591 -60.728 -30.487 -11.589
    攤薄淨收入 -98.591 -60.728 -30.487 -11.589
    攤薄後加權平均股 37.3997 36.3279 34.5218 34.5218
    扣除特別項目的每股攤薄盈利 -2.63614 -1.67166 -0.88312 -0.3357
    Dividends per Share - Common Stock Primary Issue 0 0
    每股正常攤薄盈利 -2.63614 -1.67166 -0.88312 -0.3357
    Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021
    總收入 2.112 1.393 0.813 0.508 0.752
    收入 2.112 1.393 0.813 0.508 0.752
    總營業費用 24.458 24.452 24.689 27.583 24.278
    銷售/一般/行政費用，總計 5.485 5.532 6.304 5.099 4.941
    研究與開發 18.973 18.92 18.385 22.484 19.337
    營業收入 -22.346 -23.059 -23.876 -27.075 -23.526
    利息收入（費用），非經營淨值 0.587 0.395 0.198 -0.082 0.131
    其他，淨值 0 0 0 0 0
    稅前淨收入 -21.759 -22.664 -23.678 -27.157 -23.395
    稅後淨收入 -21.759 -22.664 -23.678 -27.157 -23.395
    未計算非常項目前的淨收益 -21.759 -22.664 -23.678 -27.157 -23.395
    淨收入 -21.759 -22.664 -23.678 -27.157 -23.395
    普通股股東可獲收益 (不含非經常性項目) -21.759 -22.664 -23.678 -27.157 -23.395
    普通股股東可獲收益 (含非經常性項目) -21.759 -22.664 -23.678 -27.157 -23.395
    攤薄淨收入 -21.759 -22.664 -23.678 -27.157 -23.395
    攤薄後加權平均股 37.4543 37.2936 37.1279 37.3997 37.2068
    扣除特別項目的每股攤薄盈利 -0.58095 -0.60772 -0.63774 -0.72613 -0.62878
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    每股正常攤薄盈利 -0.58095 -0.60772 -0.63774 -0.72613 -0.62878
    • 年度
    • 每季度
    2021 2020 2019 2018
    流動資産總額 189.16 25.361 35.9 14.1
    現金和短期投資 186.219 22.838 34.826 13.634
    現金等價物 27.383 5.542 34.826 13.634
    短期投資 158.836 17.296 0 0
    Prepaid Expenses 2.941 2.523 1.074 0.466
    Total Assets 307.718 46.542 48.447 15.975
    Property/Plant/Equipment, Total - Net 30.603 16.384 11.517 1.442
    Property/Plant/Equipment, Total - Gross 32.848 17.623 12.162 1.856
    Accumulated Depreciation, Total -2.245 -1.239 -0.645 -0.414
    Other Long Term Assets, Total 2.607 4.797 1.03 0.433
    Total Current Liabilities 21.328 11.264 8.656 2.755
    Accounts Payable 3.574 1.598 2.095 0.892
    Accrued Expenses 14.885 8.164 5.962 1.823
    Notes Payable/Short Term Debt 0 0 0 0
    Current Port. of LT Debt/Capital Leases 0 0.04
    Other Current Liabilities, Total 2.869 1.502 0.599 0
    Total Liabilities 57.599 46.193 16.788 3.551
    Total Long Term Debt 0 0 0 0
    Other Liabilities, Total 36.271 34.929 8.132 0.796
    Total Equity 250.119 0.349 31.659 12.424
    Preferred Stock - Non Redeemable, Net 105.296 77.505 28.367
    Common Stock 0.00037 0.00036 0 0
    Additional Paid-In Capital 457.43 3.452 1.825 1.241
    Retained Earnings (Accumulated Deficit) -206.99 -108.399 -47.671 -17.184
    Other Equity, Total -0.32137 -0.00036 0 0
    Total Liabilities & Shareholders’ Equity 307.718 46.542 48.447 15.975
    Total Common Shares Outstanding 37.3997 36.3279 34.5218 34.5218
    Long Term Investments 85.348
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    流動資産總額 196.088 189.16 222.488 248.151 271.21
    現金和短期投資 190.901 186.219 212.893 244.988 266.669
    現金等價物 44.021 27.383 23.649 58.302 95.481
    短期投資 146.88 158.836 189.244 186.686 171.188
    Prepaid Expenses 5.187 2.941 9.595 3.163 4.541
    Total Assets 282.793 307.718 333.55 347.074 324.637
    Property/Plant/Equipment, Total - Net 29.911 30.603 30.868 30.553 15.418
    Property/Plant/Equipment, Total - Gross 32.518 32.848 32.926 32.311 16.925
    Accumulated Depreciation, Total -2.607 -2.245 -2.058 -1.758 -1.507
    Long Term Investments 54.313 85.348 77.639 65.938 36.236
    Other Long Term Assets, Total 2.481 2.607 2.555 2.432 1.773
    Total Current Liabilities 19.306 21.328 23.695 19.25 12.012
    Accounts Payable 4.446 3.574 5.155 1.614 2.888
    Accrued Expenses 11.412 14.885 13.333 13.306 7.622
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 3.448 2.869 5.207 4.33 1.502
    Total Liabilities 54.399 57.599 58.637 51.178 21.389
    Total Long Term Debt 0 0 0 0 0
    Other Liabilities, Total 35.093 36.271 34.942 31.928 9.377
    Total Equity 228.394 250.119 274.913 295.896 303.248
    Preferred Stock - Non Redeemable, Net 0 0 0
    Common Stock 0.00037 0.00037 0.00037 0.00037 0.00036
    Additional Paid-In Capital 460.458 457.43 454.784 452.357 436.165
    Retained Earnings (Accumulated Deficit) -230.668 -206.99 -179.833 -156.438 -132.853
    Other Equity, Total -1.39637 -0.32137 -0.03837 -0.02337 -0.06436
    Total Liabilities & Shareholders’ Equity 282.793 307.718 333.55 347.074 324.637
    Total Common Shares Outstanding 37.4713 37.3997 37.2481 37.191 36.3318
    • 年度
    • 每季度
    2021 2020 2019 2018
    淨收入/起跑線 -98.591 -60.728 -30.487 -11.589
    經營活動産生的現金 -57.066 -47.308 -26.343 -9.872
    經營活動産生的現金 1.193 0.611 0.335 0.302
    非現金物品 19.825 15.092 1.544 0.276
    已付現金利息 0 0.004
    營運資金的變化 20.507 -2.283 2.265 1.139
    投資活動産生的現金 -232.201 -20.592 -0.508 -0.29
    資本支出 -2.338 -3.262 -0.508 -0.29
    其他投資現金流量項目，總計 -229.863 -17.33 0 0
    融資活動産生的現金 311.108 39.597 48.627 19.094
    融資現金流項目 0 39.303 48.595 19.113
    股票的發行（報廢），淨額 311.108 0.294 0.072 0.02
    債務的發行（退還），淨額 0 -0.04 -0.039
    現金淨變化 21.841 -28.303 21.776 8.932
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Net income/Starting Line -23.678 -98.591 -71.434 -48.039 -24.454
    Cash From Operating Activities -24.314 -57.066 -39.272 -20.545 -16.559
    Cash From Operating Activities 0.357 1.193 0.832 0.528 0.272
    Non-Cash Items 4.556 19.825 16.21 12.401 8.994
    Changes in Working Capital -5.549 20.507 15.12 14.565 -1.371
    Cash From Investing Activities 40.845 -232.201 -253.234 -237.123 -190.521
    Capital Expenditures -0.605 -2.338 -1.776 -0.761 -0.058
    Other Investing Cash Flow Items, Total 41.45 -229.863 -251.458 -236.362 -190.463
    Cash From Financing Activities 0.107 311.108 310.613 310.428 297.019
    Issuance (Retirement) of Stock, Net 0.107 311.108 310.613 310.428 297.019
    Net Change in Cash 16.638 21.841 18.107 52.76 89.939
    Financing Cash Flow Items 0
    投資者名稱 投資者類型 流通股百分比 持有股份 股份變動 持有日期 換手率
    Vivo Capital, LLC Venture Capital 10.2793 3871291 0 2022-12-31 MED
    Sofinnova Investments, Inc Venture Capital 7.3138 2754437 0 2022-12-31 MED
    Citadel Advisors LLC Hedge Fund 7.3077 2752162 114 2022-12-31 HIGH
    Pivotal Bioventure Partners Investment Advisor LLC Investment Advisor 5.0224 1891467 0 2022-12-31 LOW
    Engleman Edgar G Individual Investor 3.2402 1220280 -57947 2022-03-01
    Nan Fung Group Holdings Ltd Corporation 3.0986 1166952 0 2022-12-31 LOW
    Newtyn Management, LLC Hedge Fund 3.0536 1150000 550000 2022-12-31 MED
    Samsara BioCapital, LLC Venture Capital 2.7858 1049153 0 2022-12-31 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.4648 928276 -11993 2022-12-31 LOW
    OrbiMed Advisors, LLC Investment Advisor/Hedge Fund 2.0474 771059 0 2022-12-31 LOW
    Stanford Management Company Endowment Fund 1.9106 719546 0 2022-12-31 MED
    Renaissance Technologies LLC Hedge Fund 1.1724 441539 47681 2022-12-31 HIGH
    Hawkeye Capital Management, LLC Hedge Fund 1.102 415039 0 2022-12-31 MED
    Tang Capital Management, LLC Hedge Fund 1.0621 400000 200000 2022-12-31 MED
    Goldman Sachs & Company, Inc. Research Firm 0.7515 283028 270883 2022-12-31 MED
    Oasis Management Company Ltd. Investment Advisor/Hedge Fund 0.7435 280000 0 2022-12-31 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 0.7131 268547 -153412 2022-12-31 LOW
    Millennium Management LLC Hedge Fund 0.6463 243401 125022 2022-12-31 HIGH
    Assenagon Asset Management S.A. Investment Advisor 0.5996 225816 -54165 2022-12-31 HIGH
    Bridgeway Capital Management, LLC Investment Advisor 0.4981 187600 74400 2022-12-31 LOW

    為什麼選擇Capital.com？我們用表現來證明自己。

    Capital.com Group

    500K+

    貿易商

    92K+

    每月活躍客戶

    $53M+

    每月投資額

    $30M+

    每月提取

    差價合約交易計算器

    如果您在特定日期（選取一個日期）開立差價合約交易並在不同日期（選取一個日期）關閉交易，計算您的假設盈虧。

    交易佣金
    0
    • 1:1
    槓桿
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    投資
    交易規模（槓桿 x 投資）：
    打開

    關閉

    做空 做多
    過往表現並非未來業績的可靠指標
    盈利/虧損
    Industry: Bio Therapeutic Drugs

    900 Chesapeake Drive
    REDWOOD CITY
    CALIFORNIA 94063
    US

    收入報表

    • Annual
    • Quarterly

    人們也觀看

    Natural Gas

    2.20 Price
    +3.540% 1D Chg, %
    多頭倉位隔夜費用 -0.4092%
    空頭倉位隔夜費用 0.3873%
    隔夜費時間 21:00 (UTC)
    價差 0.005

    Gold

    1,969.66 Price
    -0.550% 1D Chg, %
    多頭倉位隔夜費用 -0.0185%
    空頭倉位隔夜費用 0.0102%
    隔夜費時間 21:00 (UTC)
    價差 0.30

    US100

    13,186.80 Price
    +1.680% 1D Chg, %
    多頭倉位隔夜費用 -0.0249%
    空頭倉位隔夜費用 0.0027%
    隔夜費時間 21:00 (UTC)
    價差 3.0

    BTC/USD

    28,381.80 Price
    -0.100% 1D Chg, %
    多頭倉位隔夜費用 -0.0616%
    空頭倉位隔夜費用 0.0137%
    隔夜費時間 21:00 (UTC)
    價差 60.00

    還在尋找值得信賴的經紀商？

    加入全球 500.000 多名交易者，選擇與 Capital.com 交易

    1. 建立並驗證您的賬戶 2. 存入您的第一筆資金 3. 您已準備就緒。開始交易